Early stage biomarkers in ovarian cancer: Prof Angelo Paradiso – National Cancer Research Institute, Bari, Italy
Update: 2012-11-19
Description
Prof Angelo Paradiso discusses the process in which exploratory biomarkers move into clinical application.
The steps to move a biomarker into the clinic are very complicated, but necessary as it must be guaranteed that these markers work according to a strict quality criteria.
Prof Paradiso highlights the two main factors of the criteria as the need for standard operating producers for to clinicians and confirmation of reproducible results in a lab setting.
The steps to move a biomarker into the clinic are very complicated, but necessary as it must be guaranteed that these markers work according to a strict quality criteria.
Prof Paradiso highlights the two main factors of the criteria as the need for standard operating producers for to clinicians and confirmation of reproducible results in a lab setting.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
